▾ Celiprolol – a better beta blocker?
Keyword(s):
Celiprolol (Celectol – Rhoône Poulenc Rorer) is a new cardioselective β-blocker and vasodilator, intended for once daily treatment of mild to moderate hypertension. The manufacturer claims that “it improves the overall cardiovascular risk profile” and gives hypertensive patients “a better quality of life than can be expected from conventional β-blocker treatment”. We examine these claims.
2003 ◽
Vol 163
(20)
◽
pp. 2460
◽
Keyword(s):
2013 ◽
Vol 168
(2)
◽
pp. 898-903
◽
2004 ◽
Vol 4
(12)
◽
pp. 2140-2140
Keyword(s):
2022 ◽
Vol Volume 15
◽
pp. 545-554
2004 ◽
Vol 4
(6)
◽
pp. 937-945
◽
Keyword(s):
2004 ◽
Vol 4
(12)
◽
pp. 2139-2139
Keyword(s):
2009 ◽
Vol 5
(4)
◽
pp. 25-32
◽
2019 ◽
Vol 18
(6)
◽
pp. 492-500
◽
2019 ◽
Vol 21
(10)
◽
pp. 1456-1462
◽
2004 ◽
Vol 22
(1)
◽
pp. 51-57
◽